Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 2,366 | 2,250 | 2,135 | 1,990 | 1,852 |
| Cost of Goods | 928 | 884 | 921 | 873 | 771 |
| Gross Profit | 1,438 | 1,366 | 1,214 | 1,117 | 1,081 |
| Operating Expenses | 2,830 | 2,877 | 3,273 | 3,584 | 3,344 |
| Operating Income | -464 | -627 | -1,138 | -1,594 | -1,492 |
| Interest Expense | 83 | 58 | 33 | 8 | 0 |
| Other Income | -323 | -2,880 | -95 | -118 | 2 |
| Pre-tax Income | -870 | -3,565 | -1,266 | -1,720 | -1,491 |
| Net Income Continuous | -870 | -3,565 | -1,266 | -1,720 | -1,491 |
| Minority Interests | N/A | -242 | -297 | -364 | -264 |
| Net Income | $-870 | $-3,324 | $-969 | $-1,356 | $-1,227 |
| EPS Basic Total Ops | -0.07 | -0.25 | -0.08 | -0.11 | -0.10 |
| EPS Basic Continuous Ops | -0.07 | -0.28 | -0.10 | -0.14 | -0.12 |
| EPS Diluted Total Ops | -0.07 | -0.25 | -0.08 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | -0.07 | -0.28 | -0.10 | -0.14 | -0.12 |
| EBITDA(a) | $-313 | $-474 | $-984 | $-1,416 | $-1,432 |